At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
OPGN OpGen, Inc.
Trading 12-23 10:00:00 EST Delay
OpGen’s Strategic Moves Amid Nasdaq Delisting and New Financing
TIPRANKS  ·  08-23
OpGen’s Strategic Moves Amid Nasdaq Delisting and New Financing
BRIEF-Opgen Says Financial Statements Contained Within Quarterly Report On Form 10-Q For Q1 2024 Should No Longer Be Relied Upon
Reuters  ·  08-20
BRIEF-Opgen Says Financial Statements Contained Within Quarterly Report On Form 10-Q For Q1 2024 Should No Longer Be Relied Upon
OpGen Inc - Financial Statements Contained Within Quarterly Report on Form 10-Q for Q1 2024 Should No Longer Be Relied Upon
THOMSON REUTERS  ·  08-20
OpGen Inc - Financial Statements Contained Within Quarterly Report on Form 10-Q for Q1 2024 Should No Longer Be Relied Upon
OpGen Bolsters Board with Five New Industry Experts
TIPRANKS  ·  08-16
OpGen Bolsters Board with Five New Industry Experts
OpGen Leadership Changes: CEO Resigns, New Chairman Appointed
TIPRANKS  ·  08-03
OpGen Leadership Changes: CEO Resigns, New Chairman Appointed
OpGen Inc - Received Nasdaq Notice That Co Is Not in Compliance With Minimum Stockholders' Equity Requirement for Continued Listing on Nasdaq
THOMSON REUTERS  ·  06-12
OpGen Inc - Received Nasdaq Notice That Co Is Not in Compliance With Minimum Stockholders' Equity Requirement for Continued Listing on Nasdaq
OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
GlobeNewswire  ·  05-25
OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
OpGen to implement 1-for-10 reverse stock split
seekingalpha  ·  05-16
OpGen to implement 1-for-10 reverse stock split
BRIEF-OpGen Announces 1-For-10 Reverse Stock Split
Reuters  ·  05-16
BRIEF-OpGen Announces 1-For-10 Reverse Stock Split
OpGen Announced 1-for-10 Reverse Stock Split
GlobeNewswire  ·  05-16
OpGen Announced 1-for-10 Reverse Stock Split
OpGen Provides Update on Business Operations and Strategic Opportunities
GlobeNewswire  ·  04-29
OpGen Provides Update on Business Operations and Strategic Opportunities
OpGen receives Nasdaq notice regarding delayed Form 10-K
seekingalpha  ·  04-24
OpGen receives Nasdaq notice regarding delayed Form 10-K
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
GlobeNewswire  ·  04-23
OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K
OpGen Inc Announces David Lazar as New CEO
TIPRANKS  ·  04-17
OpGen Inc Announces David Lazar as New CEO
BRIEF-David E. Lazar Reports 19.9% Stake In Opgen Inc As Of March 25- SEC Filing
Reuters  ·  04-02
BRIEF-David E. Lazar Reports 19.9% Stake In Opgen Inc As Of March 25- SEC Filing
OpGen Inc Secures $3M Investment, Enhances Corporate Structure
TIPRANKS  ·  03-30
OpGen Inc Secures $3M Investment, Enhances Corporate Structure
Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February
Benzinga  ·  03-26
Nasdaq Gains Over 50 Points; US Durable Goods Orders Rise In February
BRIEF-Opgen Announces Acquisition Of Preferred Stock By David Lazar
Reuters  ·  03-26
BRIEF-Opgen Announces Acquisition Of Preferred Stock By David Lazar
BUZZ-OpGen jumps after private investor to take over as CEO
Reuters  ·  03-26
BUZZ-OpGen jumps after private investor to take over as CEO
OpGen Investor David Lazar Is Named CEO
Dow Jones  ·  03-26
OpGen Investor David Lazar Is Named CEO

Introduction

Company Name.
OpGen, Inc.
Affiliated Markets:
PINK
Listing Date:
--
Main Business:
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.
Issue price:
--